Ekso Bionics Holdings, Inc.
EKSO
$4.69
-$0.04-0.85%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 105.49% | -39.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 105.49% | -39.05% | |||
| Cost of Revenue | 35.54% | -21.10% | |||
| Gross Profit | 211.23% | -54.65% | |||
| SG&A Expenses | -13.72% | -3.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.68% | -9.09% | |||
| Operating Income | 64.73% | -21.93% | |||
| Income Before Tax | 47.55% | 6.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 47.55% | 6.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 47.55% | 6.30% | |||
| EBIT | 64.73% | -21.93% | |||
| EBITDA | 71.23% | -24.84% | |||
| EPS Basic | 56.29% | 27.23% | |||
| Normalized Basic EPS | 56.29% | 22.40% | |||
| EPS Diluted | 56.29% | 27.23% | |||
| Normalized Diluted EPS | 56.29% | 22.40% | |||
| Average Basic Shares Outstanding | 20.00% | 28.77% | |||
| Average Diluted Shares Outstanding | 20.00% | 28.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||